跳转至内容
Merck
CN
所有图片(1)

主要文件

J4080

Sigma-Aldrich

JTE-013

≥98% (HPLC)

别名:

1-[1,3-二甲基-4-(2-甲基乙基)-1H-吡唑并 [3,4-b] 吡啶-6-基]-4-(2,6-二氯-4-吡啶)-氨基脲

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C17H19N7OCl2
分子量:
408.29
UNSPSC代码:
12352211
NACRES:
NA.77

质量水平

方案

≥98% (HPLC)

表单

powder

颜色

white to off-white

溶解性

DMSO: ≥20 mg/mL

储存温度

2-8°C

SMILES字符串

Clc1nc(cc(c1)NC(=O)NNc2nc3[n](nc(c3c(c2)C(C)C)C)C)Cl

InChI

1S/C17H19Cl2N7O/c1-8(2)11-7-14(22-16-15(11)9(3)25-26(16)4)23-24-17(27)20-10-5-12(18)21-13(19)6-10/h5-8H,1-4H3,(H,22,23)(H2,20,21,24,27)

InChI key

RNSLRQNDXRSASX-UHFFFAOYSA-N

应用

JTE-013 已用于 体外 血液-脑屏障 (BBB) 和血-肿瘤屏障 (BTB) 试验。

生化/生理作用

JTE-013 是一种选择性 1-磷酸鞘氨醇 (S1P) 受体拮抗剂。JTE-013 对 S1P2 (EDG-5) 具有高度选择性。抑制 S1P 与人 S1P2 受体结合,IC50 值为 17.6 nM。在浓度高达 10 mM 时,JTE-013 对 S1P3 的抑制率为 4.2%,不拮抗 S1P1
JTE-013 能增强小直径感觉神经元的兴奋性。它具有抑制 1-磷酸鞘氨醇 (S1P) 介导的细胞迁移的能力。

特点和优势

该化合物在受体分类和信号转导手册中 溶血磷脂受体 页面中进行了详细介绍。想要浏览手册的其他页面, 请单击此处

象形图

Skull and crossbones

警示用语:

Danger

危险声明

危险分类

Acute Tox. 3 Oral

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Haowen Ye et al.
Frontiers in pharmacology, 12, 721200-721200 (2021-08-21)
Aims: To explore the role of the Sphingosine 1-Phosphate (S1P)/Receptor2 (S1PR2) pathway in thrombin-induced hyperpermeability (TIP) and to test whether bivalirudin can reverse TIP via the S1P-S1PRs pathway. Methods and Results: Using western blot, we demonstrated that Human umbilical vein
Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases
Gril B, et al.
Nature Communications, 9(1), 2705-2705 (2018)
K Liu et al.
Andrology, 8(2), 497-508 (2019-10-15)
Erectile dysfunction (ED) is a common complication in patients with diabetes mellitus (DM) that severely affects the patients' quality of life. However, the effectiveness of oral phosphodiesterase type 5 inhibitors in these patients is poor. Sphingosine-1-phosphate (S1P) and S1P receptor
Sphingosine 1-phosphate receptor 2 antagonist JTE-013 increases the excitability of sensory neurons independently of the receptor
Li C, et al.
Journal of Neurophysiology, 108(5), 1473-1483 (2012)
Xiaofei Sun et al.
Biochemical and biophysical research communications, 527(1), 131-137 (2020-05-25)
To investigate the expression of Nogo-A in dorsal root ganglion (DRG) in rats with cauda equina injury and the therapeutic effects of blocking Nogo-A and its receptor. Fifty-eight male Sprague-Dawley rats were divided randomly into either the sham operation group

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门